The influence of glatiramer acetate on Th17-immune response in multiple sclerosis

Glatiramer acetate (GA) is approved for the treatment of multiple sclerosis (MS). However, the mechanism of action of GA in MS is still unclear. In particular, it is not known whether GA can modulate the pro-inflammatory Th17-type immune response in MS. We investigated the effects of original GA (Co...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:PLoS One
Κύριοι συγγραφείς: Melnikov, Mikhail, Sharanova, Svetlana, Sviridova, Anastasiya, Rogovskii, Vladimir, Murugina, Nina, Nikolaeva, Anna, Dagil, Yulia, Murugin, Vladimir, Ospelnikova, Tatiana, Boyko, Alexey, Pashenkov, Mikhail
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2020
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599084/
https://ncbi.nlm.nih.gov/pubmed/33126239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0240305
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια